Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria

Kidney International

Volumn 86, Issue 6, 2014, Pages 1229-1243

  Verzola, Daniela ^a,b   Cappuccino, Laura ^a,b   D'Amato, Elena ^a   Villaggio, Barbara ^a   Gianiorio, Fabio ^a   Mij, Mariano ^c   Simonato, Alchiede ^b,d   Viazzi, Francesca ^a,b   Salvidio, Gennaro ^b   Garibotto, Giacomo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Imperia Hospital   (Italy)

^d Clinica Urologica Luciano Giuliani   (Italy)

Author keywords

Diabetic nephropathy; Inflammation; Microalbuminuria; Toll like receptors

Indexed keywords

ALBUMIN; CD4 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; COMPLEMENTARY DNA; CREATININE; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; PODOCIN; RANTES; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CCL5 PROTEIN, HUMAN; CCR2 PROTEIN, HUMAN; CCR5 PROTEIN, HUMAN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GENE EXPRESSION; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY TUMOR; MACROALBUMINURIA; MALE; MICROALBUMINURIA; MICRODISSECTION; MINIMAL CHANGE GLOMERULONEPHRITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; UPREGULATION; ALBUMINURIA; CHEMISTRY; COMPLICATION; DISEASE COURSE; FOLLOW UP; GENETICS; IMMUNOLOGY; KIDNEY TUBULE; LIPOID NEPHROSIS; METABOLISM; MIDDLE AGED;

ALBUMINURIA; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOMARKERS; CHEMOKINE CCL5; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-6; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; RECEPTORS, CCR2; RECEPTORS, CCR5; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84926140904     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.116     Document Type: Article

References (51)

1. Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 433-442.
2. Tuttle KR. Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. J Am Soc Nephrol 2005; 16: 1537-1538.
3. Furuta T, Saito T, Ootaka T et al. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 1993; 21: 480-485.
4. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-384.
5. Anders HJ, Schlö ndorff D. Toll-like receptors: emerging concepts in kidney disease. Curr Opin Nephrol Hypertens 2007; 16: 177-183.
6. Anders HJ. Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 2010; 21: 1270-1274.
7. Leemans J, Stokman G, Claessen N et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894-2903.
8. den Dekker WK, Cheng C, Pasterkamp G et al. Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis 2010; 209: 314-320.
9. Fric J, Zelante T, Wong AY et al. NFAT control of innate immunity. Blood 2012; 120: 1380-1389.
10. Dasu M, Devaraj S. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008; 57: 3090-3098.
11. Dasu MR, Devaraj S, Park S et al. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010; 33: 861-868.
12. Chow F, Ozols E, Nikolic-Paterson DJ et al. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 2004; 65: 116-128.
13. Lin M, Yiu WH, Wu HJ et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 2012; 23: 86-102.
14. Kuwabara T, Mori K, Mukoyama M et al. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 2012; 55: 2256-2266.
15. Kaur H, Chien A, Jialal I. Hyperglycemia induced Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol 2012; 303: F1145-F1150.
16. Mudaliar H, Pollock C, Komala M et al. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 2013; 305(): F143-F154.
17. Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria? Kidney Int 2006; 70: 1214-1222.
18. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease: With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983; 32(Suppl 2): 64-78.
19. Hasegawa G, Nakano K, Sawada M et al. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 1991; 40: 1007-1012.
20. Ernandez T, Mayadas TN. Immunoregulatory role of TNF-alpha in inflammatory kidney diseases. Kidney Int 2009; 76: 262-276.
21. Navarro JF, Mora C, Maca M et al. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 2003; 42: 53-61.
22. Banas MC, Banas B, Kelly L et al. TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 2008; 19: 704-713.
23. McCarthy E, Sharma R, Sharma M et al. TNF-a increases albumin permeability of isolated rat glomeruli through the generation of superoxide. J Am Soc Nephrol 1998; 9: 433-438.
24. Reiser J, von Gersdorff G, Loos M et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390-1397.
25. Levine SJ. Molecular mechanisms of soluble cytokine receptor generation. J Biol Chem 2008; 283: 14177-14181.
26. Niewczas MA, Gohda T, Skupien J et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 2012; 23: 507-515.
27. Lee JE, Gohda T, Walker WH et al. Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1. PLoS One 2013; 8: e58007.
28. Wang SN, Lapage J, Hirschberg R. Glomerular ultrafiltration and apical tubular action of IGF-I, TGF-beta, and HGF in nephrotic syndrome. Kidney Int 1999; 56: 1247-1251.
29. Tarabra E, Giunti S, Barutta F et al. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes 2009; 58: 2109-2118.
30. Chow FY, Nikolic-Paterson DJ, Ozols E et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006; 69: 73-80.
31. Ninichuk V, Clauss S, Kulkarni O et al. Late onset of CCl2 blockade with the Spiegelmer mNOX-E36-30PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice. Am J Pathol 2008; 172: 628-637.
32. Awad AS, Kinsey GR, Khutsishvili K et al. Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am J Physiol Renal Physiol 2011; 301: F1358-F1366.
33. Kato S, Luyckx VA, Ots M et al. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int 1999; 56: 1037-1048.
34. Sassy-Prigent C, Heudes D, Mandet C. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000; 49: 466-475.
35. Amann B, Tinzmann R, Angelkort B. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabetes Care 2003; 26: 2421-2425.
36. Ruggenenti P. Effects of MCP-1 inhibition by bindarit therapy in type 2 diabetes subjects with micro-or macroalbuminuria. Presented at the American Society of Nephrology Meeting, Denver, November 2010.
37. Mezzano S, Aros C, Droguett A et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 2004; 19: 2505-2512.
38. Wada T, Furuichi K, Sakai N et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000; 58: 1492-1499.
39. Schmid H, Boucherot A, Yasuda Y et al. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006; 55: 2993-3003.
40. Moriya R, Manivel JC, Mauer M. Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in type 1 diabetic patients. Diabetologia 2004; 47: 82-88.
41. Moon JY, Jeong KH, Lee TW et al. Aberrant recruitment and activation of T cells in diabetic nephropathy. Am J Nephrol 2012; 35: 164-174.
42. El-Achkar TM, Huang X, Plotkin Z et al. Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am J Physiol Renal Physiol 2103; 290: F1034-F1043.
43. Panchapakesan U, Pegg K, Gross S et al. Effects of SGLT2 inhibition in human kidney proximal tubular cells-renoprotection in diabetic nephropathy? PLoS One 2013; 8: e54442.
44. Kaur H, Chien A, Jialal I. Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol 2012; 303: F1145-F1150.
45. Sugimoto H, Shikata K, Wada J et al. Advanced glycation end productscytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: Aminoguanidine ameliorates the overexpression of tumour necrosis factor-a and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 1999; 42: 878-886.
46. Verzola D, Gandolfo MT, Ferrario F et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 2007; 72: 1262-1272.
47. Verzola D, Gandolfo MT, Gaetani G et al. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol 2008; 295: F1563-F1573.
48. Tervaertm TWC, Mooyaart AL, Amann K et al. Pathologic Classification of Diabetic Nephropathy. J Am Soc Nephrol 2010; 4: 556-563.
49. Levey AS, Stevens LA. Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 2010; 55: 622-627.
50. Verzola D, Bertolotto MB, Villaggio B et al. Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J Investig Med 2002; 50: 443-451.
51. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)). Methods 2001; 25: 402-408.